Secure your chance to win one of three iPad Pros! All you need to do is correctly answer the question
below about human milk oligosaccharides (HMOs).
Breastfeeding reduces the risk of infectious diseases in children by up to 50%. HMOs play a major role in
this process. Jennewein Biotechnologie is the pioneer and inventor of a unique fermentation process for
the production of HMOs identical to those present in human breast milk. Since 2005, our aim has been to
develop new production processes for complex oligosaccharides. In 2015, we introduced our first
food-grade HMO (2ʹ-fucosyllactose) on the market and received FDA/GRAS approval in the US and registered
novel food status in Europe.
For more information about Jennewein and HMOs click here.
JOIN THE JENNEWEIN COMPETITION
Just choose the correct answer, fill out the form, click “Send” and you will be entered in our prize draw
for one of three iPad Pros (12,9 inch/64GB/WiFi)!